In an effort to improve upon the in vivo half-life of the known ribosomal s6 kinase (RSK) inhibitor SL0101, C4″-amide/C6″-alkyl substituted analogues of SL0101 were synthesized and evaluated in cell-based assays. The analogues were prepared using a de novo asymmetric synthetic approach, which featured Pd-π-allylic catalyzed glycosylation for the introduction of a C4″-azido group. Surprisingly replacement of the C4″-acetate with a C4″-amide resulted in analogues that were no longer specific for RSK in cell-based assays.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251525 | PMC |
| http://dx.doi.org/10.1021/ol503012k | DOI Listing |
Publication Analysis
Top Keywords
c4″-amide analogues
8
analogues sl0101
8
cell-based assays
8
novo synthesis
4
synthesis biological
4
biological evaluation
4
evaluation c6″-substituted
4
c6″-substituted c4″-amide
4
analogues
4
sl0101 effort
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!